Mengli J. Huang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

Amplicon-based DNA and RNA unified NGS for enhanced fusion variant detection in suboptimal real-world NSCLC FFPE specimens.

Amplicon-based DNA and RNA unified NGS for enhanced fusion variant detection in suboptimal real-world NSCLC FFPE specimens.

Journal: Translational oncology
Published: March 13, 2026

Molecular landscape and biomarker associations of functional NTRK fusions: a real-world retrospective cohort study across solid tumors.

Molecular landscape and biomarker associations of functional NTRK fusions: a real-world retrospective cohort study across solid tumors.

Journal: Translational cancer research
Published: February 15, 2026

Molecular characterization of FGFR fusion in a large real-world population and clinical utility of bidirectional fusion.

Molecular characterization of FGFR fusion in a large real-world population and clinical utility of bidirectional fusion.

Journal: Chinese medical journal
Published: August 09, 2024

Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescence.

Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescence.

Journal: Translational lung cancer research
Published: April 29, 2024

PD-1 blockade enhances the effect of targeted chemotherapy on locally advanced pMMR/MSS colorectal cancer.

PD-1 blockade enhances the effect of targeted chemotherapy on locally advanced pMMR/MSS colorectal cancer.

Journal: Cancer medicine
Published: November 14, 2023

ASO Video Abstract: Neoadjuvant Chemo-Immunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable NSCLC.

ASO Video Abstract: Neoadjuvant Chemo-Immunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable NSCLC.

Journal: Annals of surgical oncology
Published: August 24, 2023

ASO Author Reflections: Immune Microenvironment Indicators in Neoadjuvant Chemo-Immunotherapy.

ASO Author Reflections: Immune Microenvironment Indicators in Neoadjuvant Chemo-Immunotherapy.

Journal: Annals of surgical oncology
Published: July 28, 2023

An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report.

An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report.

Journal: Frontiers in oncology
Published: March 22, 2023

Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial.

Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial.

Journal: Journal of translational medicine
Published: March 15, 2023

Anti-PD-1 plus anti-angiogenesis combined with chemotherapy in patients with HER2-negative advanced or metastatic gastric cancer: a multi-institutional retrospective study.

Anti-PD-1 plus anti-angiogenesis combined with chemotherapy in patients with HER2-negative advanced or metastatic gastric cancer: a multi-institutional retrospective study.

Journal: Journal of gastrointestinal oncology
Published: December 29, 2022

Transformation of ALK-positive NSCLC to SCLC after alectinib resistance and response to combined atezolizumab: a case report.

Transformation of ALK-positive NSCLC to SCLC after alectinib resistance and response to combined atezolizumab: a case report.

Journal: Translational lung cancer research
Published: December 24, 2022

Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection.

Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection.

Journal: Frontiers in oncology
Published: December 09, 2022
Showing 1-12 of 47

Last Updated: 09/26/2026